| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Wu,Kun-Da | Chairman | 0.43% | |
| Wang,Chao-Hui | Director | 2.21% | |
| Chen,Wei-Tai | Director | 0.27% | |
| SHENG HONG INVESTMENT CO., LTD. | Director | 2.20% | |
| MING CAI INVESTMENT CO., LTD. | Director | 0.16% | |
| Yan,Ping-He | Independent Director | 0.00% | |
| Wang,Shu-Fen | Independent Director | 0.00% | |
| Yuan,Hong-Chang | Independent Director | 0.00% |
Change Capital to 1,500,000,000
2021/01/05
Change Capital to 500,000,000
2019/07/23
Change Person in Charge to Wu,Kun-Da
2019/07/23
Change Person in Charge to Chen,Jia-Hong
2016/11/25
Change Person in Charge to Wang,Chao-Hui
2016/02/18
Change Capital to 300,000,000
2014/04/25
Change Capital to 100,000,000
2013/07/31
Change Capital to 19,000,000
2012/08/31
Change Person in Charge to Chen,Jia-Hong
2012/02/03
Change Company Name to ORIGINAL BIOMEDICALS CO., LTD.
2012/01/11
Change Capital to 15,000,000
2012/01/11
下載完整報告查看完整數據
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | - | 43 | 107 |
| Operating cost | - | 8 | 12 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | - | 35 | 95 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | - | 35 | 95 |
| Operating expenses | 33,910 | 59,297 | 40,271 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -33,910 | -59,262 | -40,176 |
| Non-operating income and expenses | 1,610 | -399 | -101 |
| Net profit (loss) before tax | -32,300 | -59,661 | -40,277 |
| Income tax expense (benefits) | - | - | - |
| Net profit (loss) of ongoing business for the current period | -32,300 | -59,661 | -40,277 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -32,300 | -59,661 | -40,277 |
| Other comprehensive profit (loss), net | - | - | - |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -32,300 | -59,661 | -40,277 |
| Net profit (loss) attributable to owners of parent company | - | - | - |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | - | - | - |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 0 | -1 | 0 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | - | - | - |
| Net cash inflows (outflows) from investing activities | - | - | - |
| Net cash inflow (outflow) from financing activities | - | - | - |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | - | - | - |
| Beginning balance of cash and cash equivalents | - | - | - |
| Ending balance of cash and cash equivalents | - | - | - |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 296,136 | 341,395 | 59,792 |
| Non-current asset | 25,583 | 29,237 | 38,245 |
| Total asset | 321,719 | 370,632 | 98,037 |
| Current liability | 12,074 | 29,857 | 10,364 |
| Non-current liability | 11,982 | 14,209 | 18,499 |
| Total liability | 24,056 | 44,066 | 28,863 |
| share capital | 659,920 | 655,500 | 470,500 |
| Equity - secruity token | - | - | - |
| capital reserve | 383,879 | 384,902 | 252,849 |
| retained earning | -746,136 | -713,836 | -654,175 |
| Other equity | - | 0 | - |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | - | - | - |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 297,663 | 326,566 | 69,174 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 442,000 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 4 | 4 | 1 |
